Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Amgen
Amgen
Page 2 of 2
Health
We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By
Investment Desk
November 2, 2017
Health
Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?
By
Tech Reporter
September 15, 2017
Health
This Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat
By
Crypto Correspondent
June 12, 2017
Health
A Heart Attack-Prevention Drug Disappoints…Wall Street
By
News Correspondent
March 17, 2017
Health
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By
Blockchain Reporter
January 7, 2017
Health
Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By
Editorial Team
August 31, 2016
Health
Amgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis
By
Editorial Team
July 19, 2016
Health
Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition
By
Contributing Writer
July 15, 2016
Health
Drug Companies Really Don’t Care About the Price Hike Backlash
By
Digital Assets Editor
July 14, 2016
Health
Merck to Axe Jobs As Part of New Research Focus
By
Senior Editor
July 13, 2016
Health
This Is the Most Important Business Trend in Pharma
By
Senior Editor
June 21, 2016
Health
Sanofi Is Shuffling Its Exec Roster Amid Continued Struggles
By
Financial Writer
May 23, 2016
Health
Another Major Insurer Is Tying Drug Prices to Health Outcomes
By
Contributing Writer
May 11, 2016
Finance
Biotech Stocks Are Down 25% So Far This Year
By
Financial Writer
May 6, 2016
Health
Amgen Just Won a Major Drug Patent Case Against Its Rivals
By
Trading Desk
March 16, 2016
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Financial Writer
Economy
The analyst who once predicted the 'end of capitalism' sees Zohran Mamdani as a 'day of reckoning coming in'—and...
By
Contributing Writer
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
News Correspondent